All posts tagged
Transgene and BMS Upgrade their Lung Cancer Combination to First Line
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
Will BMS Take Over a Danish Biotech in a Massive €500M Deal?
More News! Will BMS be acquired? “CRISPR babies aren’t unethical”?
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
A Combination of Checkpoint Inhibitors triggers new Milestone Payment
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
BMS Offers €850M for a British Oncolytic Virus better than CAR-T
Microbiomics recruited for Immuno-Oncology in a Huge New Partnership
Boehringer buys a €210M ticket to Virus-based Immuno-Oncology
BMS to combine Immuno-Oncology Blockbuster with Oxford Biotech
New Massive €250M Investment Fund Closed for European Biotech
Labiotech UG, All Rights Reserved -
Send this to friend